Posted on 03/06/2020 8:06:46 AM PST by buckalfa
SEATTLE – As Washington state grapples with coronavirus, one Seattle research institute is taking matters into their own hands.
Kaiser Permanente Washington Health Research Institute got the OK to begin its vaccine trials, the first of its kind. Its research team is enrolling 45 healthy people, ages 18 to 55, from the Seattle-area over the course of 14 months.
“[The trial] does not include any form of the live virus, and the trial will not expose participants to the virus,” said Rebecca Hughes, senior media consultant with Kaiser Permanente.
The trial is part one of three-phases that will study the safety of the vaccine and how well the immune system responds to it.
The vaccine uses a short segment of mRNA, a genetic code that can help trigger an immune response and fight infection. For example, if a person becomes infected with coronavirus, the immune response the vaccine generated when it was first injected can help fight the invading virus.
The vaccine mRNA breaks down naturally and does not remain in the body.
NEWSWEATHERSPORTSREFINEDCHIME INWATCHLIVE 40
GENERAL ALERTCoronavirus Updates SHOW MORE
GENERAL ALERT Coronavirus Updates SEE MORE 11 people have died in the King & Snohomish County areas and 70 have tested positive for COVID-19 statewide, State Dept. of Health reports.
LATEST INFO>>TESTING CRITERIA LOOSENSCORONAVIRUS COVERAGE
Kaiser Permanente recruits volunteers for 1st coronavirus vaccine trials by Karina Mazhukhina | KOMO News Thursday, March 5th 2020 AA
This undated photo provided by U.S. Centers for Disease Control and Prevention shows CDC’s laboratory test kit for the new coronavirus. (CDC via AP)
SEATTLE – As Washington state grapples with coronavirus, one Seattle research institute is taking matters into their own hands.
Kaiser Permanente Washington Health Research Institute got the OK to begin its vaccine trials, the first of its kind. Its research team is enrolling 45 healthy people, ages 18 to 55, from the Seattle-area over the course of 14 months.
“[The trial] does not include any form of the live virus, and the trial will not expose participants to the virus,” said Rebecca Hughes, senior media consultant with Kaiser Permanente.
The trial is part one of three-phases that will study the safety of the vaccine and how well the immune system responds to it.
The vaccine uses a short segment of mRNA, a genetic code that can help trigger an immune response and fight infection. For example, if a person becomes infected with coronavirus, the immune response the vaccine generated when it was first injected can help fight the invading virus.
The vaccine mRNA breaks down naturally and does not remain in the body.
Participants are asked to come to 11 in-person study visits and four phone visits over a 14-month period, including one initial screening visit, two vaccination visits, and eight follow-ups.
Patients will receive two injections of the vaccine in the upper arm with doses given 28 days apart. Different doses will be distributed to 15 people in each group:
Group 1 will receive a dose of 25 micrograms (mcg). Group 2 will receive a dose of 100 mcg. Group 3 will receive a dose of 250 mcg.
No matter which group you are in, you will receive the same dose for the first and second vaccinations. Phase one of the trial will also not test the effectiveness of the vaccine in preventing coronavirus infection. That will come in a later phase.
The vaccine is the first to be tested in humans and is similar to the mRNA vaccines developed for the Zika virus.
Participants will receive $100 for each of the in-person study visits. People who complete every visit will get $1,100
I’ve become addicted to this old typewriter I bought at the thrift store. Been typing non-stop for hours. I may have the smith-corona virus.
causes unstoppable urge to purchase additional pistols.
Woman and children first!
Kaiser Permanente is a renowned American HMO.
So this is their first coronavirus vaccination project and I wish them the best!
Could be The Royal or Underwood Strain ?
That’s a little late for next winter’s flu season. Don’t know if anyone else can move faster. Hope they get good results.
Let me suggest they pick randomly from the swamp in DC.
Kaiser Permanente is a renowned American HMO.
So this is their first coronavirus vaccination project and I wish them the best!:
My wife, relatives and a ton of friends are satisfied Patients.
Kaiser will do an excellent job in stage I evaluation of this drug.
Disclaimer: Opinions posted on Free Republic are those of the individual posters and do not necessarily represent the opinion of Free Republic or its management. All materials posted herein are protected by copyright law and the exemption for fair use of copyrighted works.